https://www.maximizemarketresearch.com/market-report/global-erectile-dysfunction-drugs-market/25288/
Erectile Dysfunction Drugs Market size was valued at USD 3.67 billion in 2023 and is expected to grow to USD 6.5 billion by 2030, representing a compound annual growth rate (CAGR) of 8.5% during the forecast period
Erectile dysfunction (ED) characterizes the inability to attain or sustain an erection adequate for satisfactory sexual performance. It's a prevalent condition, affecting over 12 million men in the United States. Vascular, neurologic, psychological, and hormonal factors can underlie this condition.
Erectile Dysfunction Drugs Market size was valued at USD 3.67 billion in 2023 and is expected to grow to USD 6.5 billion by 2030, representing a compound annual growth rate (CAGR) of 8.5% during the forecast period
Erectile dysfunction (ED) characterizes the inability to attain or sustain an erection adequate for satisfactory sexual performance. It's a prevalent condition, affecting over 12 million men in the United States. Vascular, neurologic, psychological, and hormonal factors can underlie this condition.
https://www.maximizemarketresearch.com/market-report/global-erectile-dysfunction-drugs-market/25288/
Erectile Dysfunction Drugs Market size was valued at USD 3.67 billion in 2023 and is expected to grow to USD 6.5 billion by 2030, representing a compound annual growth rate (CAGR) of 8.5% during the forecast period
Erectile dysfunction (ED) characterizes the inability to attain or sustain an erection adequate for satisfactory sexual performance. It's a prevalent condition, affecting over 12 million men in the United States. Vascular, neurologic, psychological, and hormonal factors can underlie this condition.
0 Comments
0 Shares